Selected research
Market Analysis & Forecast
Global ChIP Sequencing Service Market Analysis and Forecast 2026-2032
Market perspective
The global ChIP Sequencing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for ChIP Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for ChIP Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for ChIP Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for ChIP Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of ChIP Sequencing Service include Illumina, BGI, Creative Biolabs, Thermo Fisher Scientific, Eurofins Genomics, Diagenode, Merck, Agilent and Zymo Research, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for ChIP Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of ChIP Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for ChIP Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the ChIP Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global ChIP Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for ChIP Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.
ChIP Sequencing Service Segment by Company
Illumina
BGI
Creative Biolabs
Thermo Fisher Scientific
Eurofins Genomics
Diagenode
Merck
Agilent
Zymo Research
Chromatrap
Active Motif
ChIP Sequencing Service Segment by Type
X-ChIP
N-ChIP
ChIP Sequencing Service Segment by Application
Transcription Factor
Histone Modification and Variant Histones
Other
ChIP Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ChIP Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ChIP Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ChIP Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of ChIP Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of ChIP Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ChIP Sequencing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- X-ChIP
- N-ChIP
Applications
- Transcription Factor
- Histone Modification and Variant Histones
- Other
Companies covered
- Illumina
- BGI
- Creative Biolabs
- Thermo Fisher Scientific
- Eurofins Genomics
- Diagenode
- Merck
- Agilent
- Zymo Research
- Chromatrap
- Active Motif
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 ChIP Sequencing Service Market by Type
- 1.2.1 Global ChIP Sequencing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 X-ChIP
- 1.2.3 N-ChIP
- 1.3 ChIP Sequencing Service Market by Application
- 1.3.1 Global ChIP Sequencing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Transcription Factor
- 1.3.3 Histone Modification and Variant Histones
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 ChIP Sequencing Service Market Dynamics
- 2.1 ChIP Sequencing Service Industry Trends
- 2.2 ChIP Sequencing Service Industry Drivers
- 2.3 ChIP Sequencing Service Industry Opportunities and Challenges
- 2.4 ChIP Sequencing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global ChIP Sequencing Service Market Perspective (2021-2032)
- 3.2 Global ChIP Sequencing Service Growth Trends by Region
- 3.2.1 Global ChIP Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global ChIP Sequencing Service Market Size by Region (2021-2026)
- 3.2.3 Global ChIP Sequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global ChIP Sequencing Service Revenue by Players
- 4.1.1 Global ChIP Sequencing Service Revenue by Players (2021-2026)
- 4.1.2 Global ChIP Sequencing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global ChIP Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global ChIP Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global ChIP Sequencing Service Key Players Headquarters & Area Served
- 4.4 Global ChIP Sequencing Service Players, Product Type & Application
- 4.5 Global ChIP Sequencing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global ChIP Sequencing Service Market CR5 and HHI
- 4.6.3 2025 ChIP Sequencing Service Tier 1, Tier 2, and Tier 3
5 ChIP Sequencing Service Market Size by Type
- 5.1 Global ChIP Sequencing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global ChIP Sequencing Service Revenue by Type (2021-2032)
- 5.3 Global ChIP Sequencing Service Revenue Market Share by Type (2021-2032)
6 ChIP Sequencing Service Market Size by Application
- 6.1 Global ChIP Sequencing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global ChIP Sequencing Service Revenue by Application (2021-2032)
- 6.3 Global ChIP Sequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Illumina
- 7.1.1 Illumina Company Information
- 7.1.2 Illumina Business Overview
- 7.1.3 Illumina ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Illumina ChIP Sequencing Service Product Portfolio
- 7.1.5 Illumina Recent Developments
- 7.2 BGI
- 7.2.1 BGI Company Information
- 7.2.2 BGI Business Overview
- 7.2.3 BGI ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 BGI ChIP Sequencing Service Product Portfolio
- 7.2.5 BGI Recent Developments
- 7.3 Creative Biolabs
- 7.3.1 Creative Biolabs Company Information
- 7.3.2 Creative Biolabs Business Overview
- 7.3.3 Creative Biolabs ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Creative Biolabs ChIP Sequencing Service Product Portfolio
- 7.3.5 Creative Biolabs Recent Developments
- 7.4 Thermo Fisher Scientific
- 7.4.1 Thermo Fisher Scientific Company Information
- 7.4.2 Thermo Fisher Scientific Business Overview
- 7.4.3 Thermo Fisher Scientific ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Thermo Fisher Scientific ChIP Sequencing Service Product Portfolio
- 7.4.5 Thermo Fisher Scientific Recent Developments
- 7.5 Eurofins Genomics
- 7.5.1 Eurofins Genomics Company Information
- 7.5.2 Eurofins Genomics Business Overview
- 7.5.3 Eurofins Genomics ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Eurofins Genomics ChIP Sequencing Service Product Portfolio
- 7.5.5 Eurofins Genomics Recent Developments
- 7.6 Diagenode
- 7.6.1 Diagenode Company Information
- 7.6.2 Diagenode Business Overview
- 7.6.3 Diagenode ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Diagenode ChIP Sequencing Service Product Portfolio
- 7.6.5 Diagenode Recent Developments
- 7.7 Merck
- 7.7.1 Merck Company Information
- 7.7.2 Merck Business Overview
- 7.7.3 Merck ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Merck ChIP Sequencing Service Product Portfolio
- 7.7.5 Merck Recent Developments
- 7.8 Agilent
- 7.8.1 Agilent Company Information
- 7.8.2 Agilent Business Overview
- 7.8.3 Agilent ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Agilent ChIP Sequencing Service Product Portfolio
- 7.8.5 Agilent Recent Developments
- 7.9 Zymo Research
- 7.9.1 Zymo Research Company Information
- 7.9.2 Zymo Research Business Overview
- 7.9.3 Zymo Research ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Zymo Research ChIP Sequencing Service Product Portfolio
- 7.9.5 Zymo Research Recent Developments
- 7.10 Chromatrap
- 7.10.1 Chromatrap Company Information
- 7.10.2 Chromatrap Business Overview
- 7.10.3 Chromatrap ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Chromatrap ChIP Sequencing Service Product Portfolio
- 7.10.5 Chromatrap Recent Developments
- 7.11 Active Motif
- 7.11.1 Active Motif Company Information
- 7.11.2 Active Motif Business Overview
- 7.11.3 Active Motif ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Active Motif ChIP Sequencing Service Product Portfolio
- 7.11.5 Active Motif Recent Developments
8 North America
- 8.1 North America ChIP Sequencing Service Revenue (2021-2032)
- 8.2 North America ChIP Sequencing Service Revenue by Type (2021-2032)
- 8.2.1 North America ChIP Sequencing Service Revenue by Type (2021-2026)
- 8.2.2 North America ChIP Sequencing Service Revenue by Type (2027-2032)
- 8.3 North America ChIP Sequencing Service Revenue Share by Type (2021-2032)
- 8.4 North America ChIP Sequencing Service Revenue by Application (2021-2032)
- 8.4.1 North America ChIP Sequencing Service Revenue by Application (2021-2026)
- 8.4.2 North America ChIP Sequencing Service Revenue by Application (2027-2032)
- 8.5 North America ChIP Sequencing Service Revenue Share by Application (2021-2032)
- 8.6 North America ChIP Sequencing Service Revenue by Country
- 8.6.1 North America ChIP Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America ChIP Sequencing Service Revenue by Country (2021-2026)
- 8.6.3 North America ChIP Sequencing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe ChIP Sequencing Service Revenue (2021-2032)
- 9.2 Europe ChIP Sequencing Service Revenue by Type (2021-2032)
- 9.2.1 Europe ChIP Sequencing Service Revenue by Type (2021-2026)
- 9.2.2 Europe ChIP Sequencing Service Revenue by Type (2027-2032)
- 9.3 Europe ChIP Sequencing Service Revenue Share by Type (2021-2032)
- 9.4 Europe ChIP Sequencing Service Revenue by Application (2021-2032)
- 9.4.1 Europe ChIP Sequencing Service Revenue by Application (2021-2026)
- 9.4.2 Europe ChIP Sequencing Service Revenue by Application (2027-2032)
- 9.5 Europe ChIP Sequencing Service Revenue Share by Application (2021-2032)
- 9.6 Europe ChIP Sequencing Service Revenue by Country
- 9.6.1 Europe ChIP Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe ChIP Sequencing Service Revenue by Country (2021-2026)
- 9.6.3 Europe ChIP Sequencing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China ChIP Sequencing Service Revenue (2021-2032)
- 10.2 China ChIP Sequencing Service Revenue by Type (2021-2032)
- 10.2.1 China ChIP Sequencing Service Revenue by Type (2021-2026)
- 10.2.2 China ChIP Sequencing Service Revenue by Type (2027-2032)
- 10.3 China ChIP Sequencing Service Revenue Share by Type (2021-2032)
- 10.4 China ChIP Sequencing Service Revenue by Application (2021-2032)
- 10.4.1 China ChIP Sequencing Service Revenue by Application (2021-2026)
- 10.4.2 China ChIP Sequencing Service Revenue by Application (2027-2032)
- 10.5 China ChIP Sequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia ChIP Sequencing Service Revenue (2021-2032)
- 11.2 Asia ChIP Sequencing Service Revenue by Type (2021-2032)
- 11.2.1 Asia ChIP Sequencing Service Revenue by Type (2021-2026)
- 11.2.2 Asia ChIP Sequencing Service Revenue by Type (2027-2032)
- 11.3 Asia ChIP Sequencing Service Revenue Share by Type (2021-2032)
- 11.4 Asia ChIP Sequencing Service Revenue by Application (2021-2032)
- 11.4.1 Asia ChIP Sequencing Service Revenue by Application (2021-2026)
- 11.4.2 Asia ChIP Sequencing Service Revenue by Application (2027-2032)
- 11.5 Asia ChIP Sequencing Service Revenue Share by Application (2021-2032)
- 11.6 Asia ChIP Sequencing Service Revenue by Country
- 11.6.1 Asia ChIP Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia ChIP Sequencing Service Revenue by Country (2021-2026)
- 11.6.3 Asia ChIP Sequencing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA ChIP Sequencing Service Revenue (2021-2032)
- 12.2 SAMEA ChIP Sequencing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA ChIP Sequencing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA ChIP Sequencing Service Revenue by Type (2027-2032)
- 12.3 SAMEA ChIP Sequencing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA ChIP Sequencing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA ChIP Sequencing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA ChIP Sequencing Service Revenue by Application (2027-2032)
- 12.5 SAMEA ChIP Sequencing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA ChIP Sequencing Service Revenue by Country
- 12.6.1 SAMEA ChIP Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA ChIP Sequencing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA ChIP Sequencing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst